Chiro Rookie, 23 Oct 2012 Pfizer's new drug for RA, Tofacitinib, is supposed to replace the profits it lost when it lost patent for Lipitor, implying the…
Dove Medical Press, 21 Sep 2012 Kinase inhibitors: a new class of antirheumatic drugs The outlook for patients with rheumatoid arthritis has improved…